Navigation Links
Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
Date:2/3/2009

TSX: HAE

MONTREAL, Feb. 3 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX: HAE) announced today that Joseph Galli, Chairman and Chief Executive Officer of Haemacure will present at the BIO CEO & Investor Conference, being held February 9-10 at the Waldorf-Astoria in New York City. Mr. Galli will present a corporate progress report, including an update on the Company's lead product candidate, Hemaseel(R)HMN (fibrin sealant). The Haemacure presentation is scheduled to begin at 10 AM local time on Monday, February 9th.

The Haemacure presentation will be webcast live and may be accessed by clicking on the following link: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=HAE.TO&item_id=2086433. The presentation will also be available on the Haemacure website www.haemacure.com for a limited time following the conference.

Additional Information on the BIO CEO & Investor Conference is available at: http://www.ceo.bio.org.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant to enter pivotal Phase II/Phase III clinical trials mid-2009. Haemacure's second product candidate is thrombin, a component of its fibrin sealant, now in preclinical stage. Follow-on development will focus on the use of its fibrin sealant in adhesion prevention, aesthetics, combination with biomaterials, drug delivery, regenerative medicine, skin g
'/>"/>

SOURCE Haemacure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Announces Fiscal 2008 Results
2. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
3. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
4. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
5. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
6. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
7. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
8. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
9. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
10. Haemacure Reports on Financing Progress and Second Quarter Results
11. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Renewable energy, sustainable living, the greening ... Earth Day topics USM Studios ’ programming covers ... the affect of climate change on the planet, the ... touching on the environmental concerns affecting the nation and ... sustainable lifestyles, clean air options, and much more when ...
(Date:4/21/2015)... On Saturday, May 2nd, 2015, board certified ophthalmologist ... from Georgia Eye Physicians and Surgeons will ... held in Piedmont Park by the Lupus Foundation of ... largest LFA-sponsored walk in the nation, hosting more than ... awareness for lupus, an unpredictable and potentially fatal autoimmune ...
(Date:4/21/2015)... April 21, 2015 Invictus Medical ... prestigious Illinois university for a second innovative technology ... more conducive to newborn infants’ cognitive development. , ... NICU problems we have identified through extensive interviews ... said George Hutchinson, Invictus Medical’s Chief Technology Officer. ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 “The warm ... SunGrubbies.com. “Doesn’t every mother want to look younger than her ... is the first line of defense. Signs of ... are the evidence of too much time spent in the ... only reason to cover up. The dangers of UV ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant ... and Dine-and-Dash Spaghetti Dinner from 4 p.m. to 6 ... located in Centralia, Illinois, houses senior living apartments, affordable ... 55 and older. , Guests are invited to tour ... options for seniors. After the tours, they can take ...
Breaking Medicine News(10 mins):Health News:USM Studios’ Programming Focuses on the Environment 2Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2
... Mich. Want to keep your boss happy? Smile at ... like you mean it. A new study led by ... fake smile throughout the day worsen their mood and withdraw ... result of cultivating positive thoughts such as a tropical ...
... Use of the blood clot-inhibiting medication tifacogin does not ... pneumonia (sCAP), according to a study conducted by researchers ... The drug had shown some potential benefit in the ... The findings were published online ahead of the ...
... -- The portion of the brain responsible for visual reading ... by researchers from the Hebrew University of Jerusalem and France. ... read words in Braille show activity in precisely the same ... read. The findings challenge the textbook notion that the brain ...
... on the treatment of liver cancer, according to a ... used molecular-sized bubbles filled with chemotherapy drugs to prevent ... and mice. Researchers evaluated the use of molecular-sized ... agent. Ceramide is a lipid molecule naturally present in ...
... (MGH) researchers to shield the ovaries of female mammals ... passed an important milestone. A collaborative study with ... online in the journal Fertility and Sterility, reports that ... called FTY720 preserved the fertility of female rhesus monkeys ...
... Radiologists who interpret a high volume of mammograms may ... suspicious lesions are not malignant, according to a new study ... Radiology . "Contrary to our expectations, we observed no ... author, Diana S.M. Buist, Ph.D., M.P.H., senior investigator at the ...
Cached Medicine News:Health News:Study: For a better workday, smile like you mean it 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 3Health News:Brain doesn't need vision at all in order to 'read' material 2Health News:Brain doesn't need vision at all in order to 'read' material 3Health News:Nanotechnology may lead to new treatment of liver cancer 2Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 2Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 3Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 4Health News:Higher volume reduces false positives in screening mammography 2
(Date:4/21/2015)... April 21, 2015 The saturated European market ... the rising incidence of preterm births. This trend is ... unit (NICU) devices but also skilled and trained professionals ... Frost & Sullivan, Analysis of the Western European Infant ... of $151.5 million in 2014 and estimates this to ...
(Date:4/20/2015)... WASHINGTON , April 21, 2015  Following is ... Bureau: LIFESAVING MEDICINE ... world,s most important medicines — insulin —became available for ... of millions of people suffering from diabetes. Insulin is ... in the processing of carbohydrates in the human body. ...
(Date:4/20/2015)... YORK , April 20, 2015 This report ... by the following Segments: Toxicology Testing (In-Vivo, & In-Vitro), and ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 2Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 3U.S. Census Bureau Daily Feature for April 21 2World ADME-Toxicology Testing Industry 2World ADME-Toxicology Testing Industry 3World ADME-Toxicology Testing Industry 4World ADME-Toxicology Testing Industry 5World ADME-Toxicology Testing Industry 6World ADME-Toxicology Testing Industry 7World ADME-Toxicology Testing Industry 8World ADME-Toxicology Testing Industry 9World ADME-Toxicology Testing Industry 10World ADME-Toxicology Testing Industry 11World ADME-Toxicology Testing Industry 12World ADME-Toxicology Testing Industry 13World ADME-Toxicology Testing Industry 14World ADME-Toxicology Testing Industry 15World ADME-Toxicology Testing Industry 16World ADME-Toxicology Testing Industry 17World ADME-Toxicology Testing Industry 18World ADME-Toxicology Testing Industry 19
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: